2016
Geisler CE, Hepler C, Higgins MR, Renquist BJ. 2016. Hepatic adaptations to maintain metabolic homeostasis in response to fasting and refeeding in mice. Nutr Metab (Lond). 13:62. doi:10.1186/s12986-016-0122-x.
Goodrum F. 2016. Human Cytomegalovirus Latency: Approaching the Gordian Knot. Annu Rev Virol. 3:333–357. doi:10.1146/annurev-virology-110615-042422.
Cui T, Hester AG, Seeds MC, Rahbar E, Howard TD, Sergeant S, Chilton FH. 2016. Impact of Genetic and Epigenetic Variations Within the FADS Cluster on the Composition and Metabolism of Polyunsaturated Fatty Acids in Prostate Cancer. Prostate. 76:1182–91. doi:10.1002/pros.23205.
Kishan AU, Gomez CL, Dawson NA, Dvorak R, Foster NM, Hoyt A, Hurvitz SA, Kusske A, Silver EL, Tseng C, et al. 2016. Increasing Appropriate BRCA1/2 Mutation Testing: The Role of Family History Documentation and Genetic Counseling in a Multidisciplinary Clinic. Ann Surg Oncol. 23:634–641. doi:10.1245/s10434-016-5545-0.
Marty MT, Hoi KK, Robinson CV. 2016. Interfacing Membrane Mimetics with Mass Spectrometry. Acc Chem Res. 49:2459–2467. doi:10.1021/acs.accounts.6b00379.
Marshalek JP, Sheeran PS, Ingram P, Dayton PA, Witte RS, Matsunaga TO. 2016. Intracellular delivery and ultrasonic activation of folate receptor-targeted phase-change contrast agents in breast cancer cells in vitro. J Control Release. 243:69–77. doi:10.1016/j.jconrel.2016.09.010.
Mertens C, Akam EA, Rehwald C, Brüne B, Tomat E, Jung M. 2016. Intracellular Iron Chelation Modulates the Macrophage Iron Phenotype with Consequences on Tumor Progression. PLoS One. 11:e0166164. doi:10.1371/journal.pone.0166164.
Keenen MM and Kim S. (2016) Tumor suppressor ING4 inhibits estrogen receptor activity in breast cancer cells. Breast Cancer (Dove Med Press) 8:211-221. PMID: 27895513 Kim S. (2015) New and emerging factors in tumorigenesis: an overview. Cancer Manag Res . 2016.
Farland LV, Tamimi RM, Eliassen AH, Spiegelman D, Hankinson SE, Chen WY, Missmer SA. 2016. Laparoscopically Confirmed Endometriosis and Breast Cancer in the Nurses’ Health Study II. Obstet Gynecol. 128:1025–1031. doi:10.1097/AOG.0000000000001684.
Wongpalee SP, Vashisht A, Sharma S, Chui D, Wohlschlegel JA, Black DL. 2016. Large-scale remodeling of a repressed exon ribonucleoprotein to an exon definition complex active for splicing. Elife. 5. doi:10.7554/eLife.19743.
Tranesh G, Nassar A. 2016. Metastatic Chordoma: A Diagnostic Challenge on Fine Needle Aspiration. Case Rep Pathol. 2016:2187290. doi:10.1155/2016/2187290.
Lam WY, Becker AM, Kennerly KM, Wong R, Curtis JD, Llufrio EM, McCommis KS, Fahrmann J, Pizzato HA, Nunley RM, et al. 2016. Mitochondrial Pyruvate Import Promotes Long-Term Survival of Antibody-Secreting Plasma Cells. Immunity. 45:60–73. doi:10.1016/j.immuni.2016.06.011.
Tate TH, Baggett B, Rice PFS, Koevary JW, Orsinger GV, Nymeyer AC, Welge WA, Saboda K, Roe DJ, Hatch KD, et al. 2016. Multispectral fluorescence imaging of human ovarian and fallopian tube tissue for early-stage cancer detection. J Biomed Opt. 21:56005. doi:10.1117/1.JBO.21.5.056005.
Strom J, Xu B, Tian X, Chen QM. 2016. Nrf2 protects mitochondrial decay by oxidative stress. FASEB J. 30:66–80. doi:10.1096/fj.14-268904.
Jiralerspong S, Goodwin PJ. 2016. Obesity and Breast Cancer Prognosis: Evidence, Challenges, and Opportunities. J Clin Oncol. 34:4203–4216. doi:10.1200/JCO.2016.68.4480.
Marlowe TA, Lenzo FL, Figel SA, Grapes AT, Cance WG. 2016. Oncogenic Receptor Tyrosine Kinases Directly Phosphorylate Focal Adhesion Kinase (FAK) as a Resistance Mechanism to FAK-Kinase Inhibitors. Mol Cancer Ther. 15:3028–3039. doi:10.1158/1535-7163.MCT-16-0366.
Garcia DO, Lander EM, Wertheim BC, Manson JE, Volpe SL, Chlebowski RT, Stefanick ML, Lessin LS, Kuller LH, Thomson CA. 2016. Pet Ownership and Cancer Risk in the Women’s Health Initiative. Cancer Epidemiol Biomarkers Prev. 25:1311–6. doi:10.1158/1055-9965.EPI-16-0218.
Yao M, Woods C, Lavertu P, Fu P, Gibson M, Rezaee R, Zender C, Wasman J, Sharma N, Machtay M, et al. 2016. Phase II study of erlotinib and docetaxel with concurrent intensity-modulated radiotherapy in locally advanced head and neck squamous cell carcinoma. Head Neck. 38 Suppl 1:E1770–6. doi:10.1002/hed.24313.
Martinez JA, Chalasani P, Thomson CA, Roe D, Altbach M, Galons J-P, Stopeck A, Thompson PA, Villa-Guillen DE, Chow H-HS. 2016. Phase II study of metformin for reduction of obesity-associated breast cancer risk: a randomized controlled trial protocol. BMC Cancer. 16:500. doi:10.1186/s12885-016-2551-3.
Warfel NA, Sainz AG, Song JH, Kraft AS. 2016. PIM Kinase Inhibitors Kill Hypoxic Tumor Cells by Reducing Nrf2 Signaling and Increasing Reactive Oxygen Species. Mol Cancer Ther. 15:1637–47. doi:10.1158/1535-7163.MCT-15-1018.
Patel S, Ragab O, Kamrava M. 2016. Real-time image guidance for gynecologic brachytherapy?. Radiother Oncol. 120:542–543. doi:10.1016/j.radonc.2016.03.018.
Janda J, Burkett NB, Blohm-Mangone K, Huang V, Curiel-Lewandrowski C, Alberts DS, Petricoin EF, Calvert VS, Einspahr J, Dong Z, et al. 2016. Resatorvid-based Pharmacological Antagonism of Cutaneous TLR4 Blocks UV-induced NF-κB and AP-1 Signaling in Keratinocytes and Mouse Skin. Photochem Photobiol. 92:816–825. doi:10.1111/php.12659.
Ruiz, J. M., Hamann, H. H., O’Connor, M. F., & Mehl, M. (2016). The Hispanic Health Paradox: From Epidemiological Phenomenon to Contribution Opportunities for Psychological Science. Group Processes & Intergroup Relations, 19, 462-476. 2016.
Lance P, Thompson PA, Ashbeck EL, Roe DJ, Fales L, Buckmeier J, Wang F, Bhattacharyya A, Hsu C-H, Sherry Chow HH, et al. 2016. Selenium Supplementation for Prevention of Colorectal Adenomas and Risk of Associated Type 2 Diabetes. J Natl Cancer Inst. 108. doi:10.1093/jnci/djw152.
Jandova J, Xu W, Nfonsam V. 2016. Sporadic early-onset colon cancer expresses unique molecular features. J Surg Res. 204:251–60. doi:10.1016/j.jss.2016.04.068.
Pagination
- First page
- …
- 31
- 32
- 33
- …
- Last page